Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modeling cumulative overall prevention efficacy for the VRC01 phase 2b efficacy trials
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume -, Issue -, Pages 1-12
Publisher
Informa UK Limited
Online
2018-04-24
DOI
10.1080/21645515.2018.1462640
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Use of broadly neutralizing antibodies for HIV-1 prevention
- (2017) Amarendra Pegu et al. IMMUNOLOGICAL REVIEWS
- Complex immune correlates of protection in HIV-1 vaccine efficacy trials
- (2017) Georgia D. Tomaras et al. IMMUNOLOGICAL REVIEWS
- Population pharmacokinetics analysis of VRC01, an HIV-1 broadly neutralizing monoclonal antibody, in healthy adults
- (2017) Yunda Huang et al. mAbs
- Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial
- (2017) Kenneth H. Mayer et al. PLOS MEDICINE
- A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges
- (2016) Rajeev Gautam et al. NATURE
- Features of Recently Transmitted HIV-1 Clade C Viruses that Impact Antibody Recognition: Implications for Active and Passive Immunization
- (2016) Cecilia Rademeyer et al. PLoS Pathogens
- Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection
- (2016) Kshitij Wagh et al. PLoS Pathogens
- Broadly Neutralizing Anti-HIV Antibodies Prevent HIV Infection of Mucosal TissueEx Vivo
- (2015) Yanille M. Scott et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Safety, pharmacokinetics and neutralization of the broadly neutralizing HIV-1 human monoclonal antibody VRC01 in healthy adults
- (2015) J. E. Ledgerwood et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection
- (2015) Kevin O. Saunders et al. JOURNAL OF VIROLOGY
- History of passive antibody administration for prevention and treatment of infectious diseases
- (2015) Barney S. Graham et al. Current Opinion in HIV and AIDS
- Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies
- (2015) Laura E. McCoy et al. PLoS Pathogens
- Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor
- (2014) A. Pegu et al. Science Translational Medicine
- HIV Monoclonal Antibodies: A New Opportunity to Further Reduce Mother-to-Child HIV Transmission
- (2014) Yegor Voronin et al. PLOS MEDICINE
- A Human Antibody to the CD4 Binding Site of gp120 Capable of Highly Potent but Sporadic Cross Clade Neutralization of Primary HIV-1
- (2013) Johannes S. Gach et al. PLoS One
- Coverage of primary mother-to-child HIV transmission isolates by second-generation broadly neutralizing antibodies
- (2012) Kyle J. Nakamura et al. AIDS
- Short Communication: HIV Type 1 Subtype C Variants Transmitted Through the Bottleneck of Breastfeeding Are Sensitive to New Generation Broadly Neutralizing Antibodies Directed Against Quaternary and CD4-Binding Site Epitopes
- (2012) Elizabeth S. Russell et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- The origin and diversity of the HIV-1 pandemic
- (2012) Joris Hemelaar TRENDS IN MOLECULAR MEDICINE
- Phenotypic and Immunologic Comparison of Clade B Transmitted/Founder and Chronic HIV-1 Envelope Glycoproteins
- (2011) C. B. Wilen et al. JOURNAL OF VIROLOGY
- Prevention of HIV-1 Infection with Early Antiretroviral Therapy
- (2011) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
- (2010) Robert M. Grant et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
- (2010) T. Zhou et al. SCIENCE
- Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
- (2010) X. Wu et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now